Published Under Research Excellence Development Program (RED), one of the essential annual activities of SiCOREs is the interaction with Scientific Advisory Board members (SAB) to assess the progress of the research program against their project milestones, along with a discussion with SAB on ideas for improvement. This year, the meeting schedules are as follows;
On 8 July 2022, SiCORE-Dengue – Assoc. Prof. Dr. Panisadee Avirutnan (Director), researchers, and SiCORE-M participated in the Teleconference with the Scientific Advisory Board members (SAB), namely Prof. Sir Andrew J. McMichael from the University of Oxford and Prof. Xiao-Ning Xu from Imperial College London for the 3rd year Research Program Evaluation for the Center of Research Excellence in Dengue and Emerging Pathogens.
On 18 July 2022, SiCORE-Allergy – Assoc. Prof. Pongsakorn Tantilipikorn (Director), Assoc. Prof. Nitat Sookrung, researchers, and SiCORE-M teams had the Hybrid meeting with Scientific Advisory Board members (SAB), namely Prof. Rudolf Valenta from the Medical University of Vienna and Prof. Stephen R. Durham from Imperial College London participated via a virtual platform. In addition, on this particular occasion, Prof. Giorgio Walter Canonica from Humanitas University joined an in-person meeting during his visit Faculty of Medicine Siriraj Hospital on the same day. There was a discussion on the 3rd year Research Program Evaluation for the Center of Research Excellence in Allergy and Immunology.
The World Allergy Organization (WAO), an international umbrella organization whose members consist of 103 regional and national allergology and clinical immunology societies, endorsed SiCORE Allergy & Immunology as a Center of Excellence (COE) for the term 2022-2024. To become the first COE in ASEAN and the 4th in Asia (after China, Japan, and South Korea), we can collaborate with other COE to provide scientific support and educational resources on a global scale. Furthermore, we could form international partnerships for research and education activities.
On 18 July 2022, SiCORE-CVD – Prof. Rungroj Krittayaphong, Director of SiCORE-Cardiovascular disease and Assoc. Prof. Sith Sathornsumetee, Manager of Siriraj Center of Research Excellence Management Unit (SiCORE-M), along with his team, joined the meeting with the Scientific Advisory Board members (SAB), namely Prof. Gregory Lip from the University of Liverpool, Prof. Gemma Figtree from University of Sydney and Assoc Prof. Jin Joo Park from Seoul National University for the 2nd year Research Program Evaluation for the Center of Research Excellence in Cardiovascular Disease.
On 4 August 2022, SiCORE-PM&SP – Assist. Prof. Dr. Somponnat Sampattavanich (Director), researchers, and SiCORE-M participated in the meeting with Scientific Advisory Board members (SAB), namely Prof. Andrew Futreal from the University of Texas MD Anderson Cancer Center and Prof. Christopher L. Corless from Oregon Health and Science University for the 3rd year Research Program Evaluation for the Center of Research Excellence in Cancer Precision Medicine and Systems Pharmacology.
